PULSION MEDICAL SYSTEMS SE Inactive Instrument
Pulsion Medical Systems SE Stock Deutsche Boerse AG
Equities
DE0005487904
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| Sales 2020 | 32.06M 34.3M | Sales 2021 | 27.95M 29.91M | Capitalization | 160M 171M |
|---|---|---|---|---|---|
| Net income 2020 | 9M 9.63M | Net income 2021 | 5M 5.35M | EV / Sales 2020 | 5.61 x |
| Net cash position 2020 | 238 254.64 | Net cash position 2021 | 142 151.93 | EV / Sales 2021 | 5.72 x |
| P/E ratio 2020 |
19
x | P/E ratio 2021 |
27
x | Employees | - |
| Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 99.94% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Stephan Haft
CEO | Chief Executive Officer | - | 10-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Stephan Haft
CEO | Chief Executive Officer | - | 10-12-31 |
Magnus Isaksson
BRD | Director/Board Member | - | 22-06-29 |
Jens Viebke
CHM | Chairman | 57 | - |
Pulsion Medical Systems SE is a Germany-based company that develops and markets minimally invasive physiological monitoring systems for use in intensive care stations and in operating rooms. The Company's products are used primarily to monitor blood circulatory systems in patients. Pulsion also markets disposable measuring catheters and the intravenous diagnostic dye Indocyanine Green. The Company operates worldwide. On February 19, 2014, Getinge AB secured 78.55% of the outstanding shares in Pulsion Medical Systems SE.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.28% | 186B | |
| -1.85% | 107B | |
| -3.82% | 67.57B | |
| +7.88% | 50.7B | |
| +16.13% | 47.2B | |
| -0.45% | 39.72B | |
| +9.73% | 27.48B | |
| +2.23% | 25.65B | |
| +13.37% | 24.97B |
